Ahmet Aydın (A Aydın, Ahmet Aydin, A Aydin)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 6

Top Topics

Hyaluronic Acid

Risk Assessment

Listeria Monocytogenes

Top Venues

Pharmaceutical development and technology

Human & experimental toxicology

Toxicological research

This page only lists publications with an associated author ORCID identifier.

Publications

Panoraia I Siafaka, Emre Şefik Çağlar, Hande Sipahi, Mohammad Charehsaz, Ahmet Aydın, Neslihan Üstündağ Okur
Ocular microemulsion of brinzolamide: Formulation, physicochemical characterization, and in vitro irritation studies based on EpiOcular™ eye irritation assay. Pharmaceutical development and technology 26 (7) (2021)
Mohammad Charehsaz, S Helvacıoğlu, S Çetinkaya, R Demir, O Erdem, Ahmet Aydın
Heavy metal and essential elements in beers from turkey market: A risk assessment study. Human & experimental toxicology 40 (8) (2021)
Muhammet Davut Arpa, Ayşegül Yoltaş, Ecehan Onay Tarlan, Cemre Şahin Şenyüz, Hande Sipahi, Ahmet Aydın, Neslihan Üstündağ Okur
New therapeutic system based on hydrogels for vaginal candidiasis management: formulation-characterization and in vitro evaluation based on vaginal irritation and direct contact test. Pharmaceutical development and technology 25 (10) (2020)
Mohammad Charehsaz, Gulcin Tugcu, Ahmet Aydın
Filling data gap for nicotinic acid, nicotinate esters and nicotinamide for the determination of permitted daily exposure by a category approach. Toxicological research 37 (3) (2020)
İpek Erol, Neslihan Üstündağ Okur, Duygu Orak, Hande Sipahi, Ahmet Aydın, Ozgen Ozer
Tazarotene-loaded in situ gels for potential management of psoriasis: biocompatibility, anti-inflammatory and analgesic effect. Pharmaceutical development and technology 25 (8) (2020)
R Reis, Hande Sipahi, O Dinc, T Kavaz, M Charehsaz, A Dimoglo, Ahmet Aydın
Toxicity, mutagenicity and stability assessment of simply produced electrolyzed water as a wound healing agent in vitro. Human & experimental toxicology 40 (3) (2020)